NCT03570255View on ClinicalTrials.gov

Feasibility and Performance Evaluation for INVSENSOR00024

NACompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

June 25, 2018

Primary Completion Date

November 8, 2019

Study Completion Date

November 8, 2019

Conditions

Evaluation of SpO2 Performance

Interventions

DEVICE

RD SET Neo SpO2

All subjects are enrolled in the experimental group and receive the RD SET Neo SpO2 sensor.

Trial Locations (1)

94305

Stanford University Medical Center, Stanford

Sponsors

Lead Sponsor

Masimo Corporation

All Listed Sponsors

lead

Masimo Corporation

INDUSTRY